Publications:

---

MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.

Bmj Open

Brown, Sarah S; Sherratt, Debbie D; Hinsley, Samantha S; Flanagan, Louise L; Roberts, Sadie S; Walker, Katrina K; Hall, Andrew A; Pratt, Guy G; Messiou, Christina C; Jenner, Matthew M; Kaiser, Martin M; ,

Publication Date: 2021-03-24

Variant appearance in text: HR: ser3*

PubMed Link: 33762245

Variant Present in the following documents:

• bmjopen-2020-046225.draft_revisions.pdf

View BVdb publication page

---

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer.

The Journal Of Experimental Medicine

Hedberg, Matthew L ML; Peyser, Noah D ND; Bauman, Julie E JE; Gooding, William E WE; Li, Hua H; Bhola, Neil E NE; Zhu, Tian Ran TR; Zeng, Yan Y; Brand, Toni M TM; Kim, Mi-Ok MO; Jordan, Richard C K RCK; VandenBerg, Scott S; Olivas, Victor V; Bivona, Trever G TG; Chiosea, Simion I SI; Wang, Lin L; Mills, Gordon B GB; Johnson, Jonas T JT; Duvvuri, Umamaheswar U; Ferris, Robert L RL; Ha, Patrick P; Johnson, Daniel E DE; Grandis, Jennifer R JR

Publication Date: 2019-02-04

Variant appearance in text: HR: ser3*

PubMed Link: 30683736

Variant Present in the following documents:

• JEM_20181936.pdf

View BVdb publication page

---

A systematic scoping review on the consequences of stress-related hyperglycaemia.

Plos One

Olariu, Elena E; Pooley, Nicholas N; Danel, Aurélie A; Miret, Montserrat M; Preiser, Jean-Charles JC

Publication Date: 2018

Variant appearance in text: HR: ser3*

PubMed Link: 29624594

Variant Present in the following documents:

• pone.0194952.pdf

View BVdb publication page

---

Culicidae community composition and temporal dynamics in Guapiaçu Ecological Reserve, Cachoeiras de Macacu, Rio de Janeiro, Brazil.

Plos One

Alencar, Jeronimo J; de Mello, Cecilia Ferreira CF; Guimarães, Anthony Érico AÉ; Gil-Santana, Hélcio R HR; Silva, Júlia Dos Santos Jdos S; Santos-Mallet, Jacenir R JR; Gleiser, Raquel M RM

Publication Date: 2015

Variant appearance in text: HR: ser3*

PubMed Link: 25815724

Variant Present in the following documents:

• pone.0122268.pdf

View BVdb publication page

---

The use of pill counts as a facilitator of adherence with antiretroviral therapy in resource limited settings.

Plos One

Achieng, Loice L; Musangi, Helen H; Billingsley, Katherine K; Onguit, Sharon S; Ombegoh, Edwin E; Bryant, LeeAnn L; Mwiindi, Jonathan J; Smith, Nathaniel N; Keiser, Philip P

Publication Date: 2013

Variant appearance in text: HR: ser3*

PubMed Link: 24339861

Variant Present in the following documents:

• pone.0067259.pdf

View BVdb publication page

---

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge.

Thrombosis Journal

Wang, Li L; Sengupta, Nishan N; Baser, Onur O

Publication Date: 2011-10-13

Variant appearance in text: HR: ser3*

PubMed Link: 21995820

Variant Present in the following documents:

• 1477-9560-9-15.pdf

View BVdb publication page

---

The origins of novel protein interactions during animal opsin evolution.

Plos One

Plachetzki, David C DC; Degnan, Bernard M BM; Oakley, Todd H TH

Publication Date: 2007-10-17

Variant appearance in text: HR: SeR3x

PubMed Link: 17940617

Variant Present in the following documents:

View BVdb publication page

---